Chondrocalcinosis of the Temporomandibular Joint: A Parotid Pseudotumor

A case of destructive calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: a diagnostic challenge

“…CPPD manifested as a preauricular swelling could also mimic a parotid tumour 5,32,41 or a secondary infection of the TMJ. CPPD could mimic a symptomatic temporomandibular disease with preauricular pain and limitation of mouth opening because of the nonspecific symptoms, but swelling in the TMJ region, especially in elderly women, should be investigated further.…”

Calcium pyrophosphate dihydrate arthropathy with condylar destruction of the temporomandibular joint

“…Involvement of the TMJ is rare, and the first report of calcium pyrophosphate dihydrate arthropathy of the TMJ was made by Pritzker et al (1). Only 20 cases of this condition affecting the TMJ have been reported (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). In the literature, this disease develops more frequently in women (16 cases, 80%), particularly those aged 50-60 years (average age, 57.4 years).…”

“…Other associated conditions or diseases include osteoarthritis, hypothyroidism, amyloidosis, trauma, and surgical intervention. In the literature, coexistent systemic diseases considered to be closely associated with CPPD of the TMJ, including diabetes mellitus, CPPD in the wrist and knee, generalized arthritis, polymyalgia rheumatica, hypothyroidism, hypertension and hiatal hernia, have been described in 8 patients out of 20 reported cases (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). CPPD deposition disease of the TMJ usually involves the condyle and fibrocartilage (11 out of 20 cases) (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16).…”

Bilateral temporomandibular joint pseudogout

“…Colchicine is more often associated with the treatment of gout, and is intended to be given during an acute phase. It inhibits the release of a chemotactic factor by polymorphonuclear leucocytes 17 after phagocytosis of CPPD crystals. 1 0.5-2 milligrams of colchicine intravenously may predictably control acute pseudogout.…”